查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593038

靜脈針市場：按規格、最終用戶分類 - 2025-2030 年全球預測

Intravenous Needles Market by Gauges (18 Gauge, 20 Gauge, 22 Gauge), End User (Diagnostic Centers, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年靜脈注射針市場價值為20.3億美元，預計2024年將達到21.4億美元，複合年成長率為6.18%，到2030年將達到30.9億美元。

靜脈針市場範圍包括設計用於將藥物、營養物質和液體直接注射到患者靜脈中的醫療設備，這在醫院、門診護理、家庭保健和緊急醫療服務等環境中非常重要。這種需求源自於有效藥物輸送的必要性，尤其是對於重症患者和慢性疾病患者。靜脈針主要用於化療、脫水治療、輸血、疼痛管理等。最終用戶範圍從醫療保健提供者到專科診所和居家醫療，隨著慢性病的流行和人口老化，需求不斷增加。

主要市場統計
基準年[2023] 20.3億美元
預測年份 [2024] 21.4億美元
預測年份 [2030] 30.9億美元
複合年成長率（%） 6.18%

主要成長動力包括安全設計針等技術進步、全球醫療保健支出增加以及發展中地區獲得醫療保健的機會擴大。由於患者更喜歡在醫院外接受治療，家庭醫療保健市場的快速成長將進一步推動需求。醫療基礎設施不斷擴張的新興市場存在機會。公司可以透過專注於產品安全、減少針刺傷害以及整合智慧技術來監控藥品管理來利用技術創新。

由於嚴格的監管要求和高品質合規性的需要，也存在挑戰。主要由於市場競爭動態和報銷問題造成的定價壓力可能會限制成長。此外，COVID-19 大流行擾亂了供應鏈並暫時影響了市場穩定。

創新領域包括開發具有增強安全機制的針頭、開發減少醫療廢棄物的環保材料以及追蹤患者使用和管理效率的數位整合。與高科技公司建立夥伴關係來開發智慧針頭解決方案可能會帶來改變。此外，進行成本效益分析來證明先進針頭溢價的合理性可以提高市場滲透率。為了在這競爭格局中獲得優勢，建議繼續投資研發。儘管市場競爭仍然激烈，但隨著重點轉向以患者為中心的解決方案和居家照護創新，存在巨大的成長潛力。

市場動態：揭示快速發展的靜脈針市場的關鍵市場洞察

供需的動態交互作用正在改變靜脈注射針市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 醫療手術和程序數量的增加
    • 在嚴重監護環境中增加靜脈注射針的使用
    • 家庭保健和自我用藥的新趨勢
  • 市場限制因素
    • 原料成本波動和產品召回
  • 市場機會
    • 將靜脈注射針相關產品融入遠端醫療
    • 輸液針製造的進展
  • 市場挑戰
    • 擔心針刺傷

波特五力：駕馭靜脈針市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對靜脈針市場的影響

外部宏觀環境因素在塑造靜脈針市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解靜脈針市場的競爭狀況

靜脈針市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣靜脈針市場供應商的績效評估

FPNV定位矩陣是評估靜脈針市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定靜脈針市場成功之路的策略分析與建議

對於旨在加強其在全球市場的影響力的公司來說，對靜脈針市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療手術和程序的增加
      • 加護病房中靜脈注射針的使用增加
      • 家庭保健和自我用藥的新趨勢
    • 抑制因素
      • 原料成本波動和產品召回
    • 機會
      • 輸液針相關產品與遠端醫療的整合
      • 靜脈注射針製造的進步
    • 任務
      • 擔心針刺傷
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 靜脈針市場測算

  • 18號
  • 20號
  • 22號

第7章 靜脈針市場：依最終使用者分類

  • 診斷中心
  • 醫院/診所

第8章美洲靜脈針市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太靜脈針市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲靜脈針市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam Inc.
  • Advin Health Care
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomedical Srl
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Freudenberg Medical, LLC
  • Medtronic PLC
  • Merck KGaA
  • Novo Nordisk A/S
  • Olympus Corporation
  • PerkinElmer, Inc.
  • QIAGEN
  • Shimadzu Corporation
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated.
  • Thermo Fisher Scientific Inc.
  • Volkmann MedizinTechnik GmbH
  • Zhejiang Longde Pharmaceutical Co., Ltd.
Product Code: MRR-F6513A06BEEA

The Intravenous Needles Market was valued at USD 2.03 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 3.09 billion by 2030.

The market scope for intravenous needles encompasses medical devices designed for infusing medications, nutrients, or fluids directly into patients' veins, critical in settings such as hospitals, ambulatory care, home healthcare, and emergency medical services. Their necessity is driven by the essential requirement for efficient drug delivery, especially in critical and chronic care scenarios. Intravenous needles are predominantly used in chemotherapy, dehydration treatment, blood transfusion, and pain management. The end-users range from healthcare providers to specialized clinics and home healthcare settings, where demand is tied to the rise in chronic disease prevalence and aging populations.

KEY MARKET STATISTICS
Base Year [2023] USD 2.03 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 3.09 billion
CAGR (%) 6.18%

Key growth-fostering factors include technological advancements like safety-engineered needles, increasing global healthcare expenditures, and expanded healthcare access in developing regions. The burgeoning home healthcare market further enhances demand, as patients prefer treatment outside hospital settings. Opportunities lie in emerging markets where healthcare infrastructure is expanding. Companies can leverage innovation by focusing on product safety, reducing needlestick injuries, and integrating smart technologies to monitor medication delivery.

Challenges persist due to stringent regulatory requirements and the need for high-quality compliance. Pricing pressures, primarily due to competitive market dynamics and reimbursement issues, may restrain growth. Moreover, the COVID-19 pandemic has disrupted supply chains, affecting market stability temporarily.

Innovation areas include developing needles with enhanced safety mechanisms, eco-friendly materials to reduce medical waste, and digital integration for tracking patient usage and dosage efficiency. Fostering partnerships with tech firms to develop smart needle solutions could be transformative. Additionally, conducting cost-benefit analyses to justify the premium pricing of advanced needles could aid market penetration. Continuous R&D investment is recommended to stay ahead in this competitive landscape. The market remains highly competitive with significant potential for growth as focus shifts towards patient-centric solutions and homecare innovations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Needles Market

The Intravenous Needles Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in number of medical surgeries and procedures
    • Growing use of IV needles in critical care settings
    • Emerging trend of home healthcare and self-administration of drugs
  • Market Restraints
    • Volatility in raw material cost and incidences of product recall
  • Market Opportunities
    • Integration of IV needle-related products with telemedicine
    • Advancements in IV needle manufacturing
  • Market Challenges
    • Concerns associated with needlestick injuries

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Needles Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Needles Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Needles Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Needles Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Needles Market

A detailed market share analysis in the Intravenous Needles Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Needles Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Needles Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Needles Market

A strategic analysis of the Intravenous Needles Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Needles Market, highlighting leading vendors and their innovative profiles. These include Abcam Inc., Advin Health Care, Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomedical Srl, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Freudenberg Medical, LLC, Medtronic PLC, Merck KGaA, Novo Nordisk A/S, Olympus Corporation, PerkinElmer, Inc., QIAGEN, Shimadzu Corporation, Siemens AG, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated., Thermo Fisher Scientific Inc., Volkmann MedizinTechnik GmbH, and Zhejiang Longde Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Gauges, market is studied across 18 Gauge, 20 Gauge, and 22 Gauge.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in number of medical surgeries and procedures
      • 5.1.1.2. Growing use of IV needles in critical care settings
      • 5.1.1.3. Emerging trend of home healthcare and self-administration of drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Volatility in raw material cost and incidences of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of IV needle-related products with telemedicine
      • 5.1.3.2. Advancements in IV needle manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with needlestick injuries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Needles Market, by Gauges

  • 6.1. Introduction
  • 6.2. 18 Gauge
  • 6.3. 20 Gauge
  • 6.4. 22 Gauge

7. Intravenous Needles Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals & Clinics

8. Americas Intravenous Needles Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Intravenous Needles Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Needles Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Inc.
  • 2. Advin Health Care
  • 3. Argon Medical Devices, Inc.
  • 4. B. Braun SE
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biomedical Srl
  • 8. Boston Scientific Corporation
  • 9. Cardinal Health, Inc.
  • 10. Cook Group Incorporated
  • 11. Freudenberg Medical, LLC
  • 12. Medtronic PLC
  • 13. Merck KGaA
  • 14. Novo Nordisk A/S
  • 15. Olympus Corporation
  • 16. PerkinElmer, Inc.
  • 17. QIAGEN
  • 18. Shimadzu Corporation
  • 19. Siemens AG
  • 20. Smith & Nephew PLC
  • 21. Stryker Corporation
  • 22. Teleflex Incorporated.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Volkmann MedizinTechnik GmbH
  • 25. Zhejiang Longde Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS NEEDLES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS NEEDLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS NEEDLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAVENOUS NEEDLES MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 18 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 20 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 22 GAUGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023